Araştırma Makalesi
BibTex RIS Kaynak Göster

Economic Burden of Obesity-Related Comorbidities in Turkey

Yıl 2019, Cilt: 8 Sayı: 3, 223 - 230, 30.09.2019

Arzu Yiğit , Vahit Yiğit

Öz

Obezite ve obeziteye bağlı hastalıklar tüm dünyada önde gelen ölüm nedenidir ve neden oldukları mortalite ve morbiditeler önemli bir halk sağlığı sorununu oluşturmaktadır. Bu araştırmanın amacı,Türkiye'de 2004 ve 2015 yılları için obeziteye bağlı komorbiditelerin ekonomik yükünü analiz etmektir.Hastalık yükü çalışmalarında kullanılan yöntemlerden en önemlisi Engelliğe Bağlı Yaşam Yılları (Disability adjusted life years-DALY) yaklaşımıdır. Obezitenin ekonomik yükünü hesaplamak için, DALY ve gayrisafi yurtiçi hasıladan (GSYİH) kişi başına düşen pay verileri kullanılmıştır. Obezite ve buna bağlı komorbiditelerin DALY değerleri, Sağlık Bakanlığı tarafından yayınlanan "Türkiye Hastalık Yükü  Çalışması"ndan alınmıştır. Obeziteye neden olan hastalıkların ekonomik yükü DALY metodolojisine göre tahmin edilmiştir. Türkiye’de obezite ilişkili komorbiditelerin ekonomik yükü 2004 yılında 4.692.333.776-$ olarak tahmin edilmiştir. Bu tutar gayri safi yurtiçi hasılasının %1,20’isini oluşturmaktadır. 2015 yılında ise obezite ilişkili komorbiditelerin ekonomik yükü ise 17.646.245.880-$ ve gayri safi yurtiçi hasılasının %2,45’ini
oluşturmaktadır. Obez nüfusun artışı dikkate alındığında obeziteye bağlı hastalıkların ekonomik yükününün ilerleyen yıllarda daha da artacağı düşünülmektedir. Obezite ile ilişkili komorbiditeler,
Türkiye bütçesine önemli bir mali yük oluşturmaktadır. Obezite tedavi edilebilen önemli bir halk sağlığı problemdir. Sağlık hizmetlerine ayrılan kıt kaynakları daha verimli ve etkin kullanabilmek
için, Türkiye’de obezitenin ekonomik yükünü dikkate değer ölçüde düşürmek gerekmektedir.  

Anahtar Kelimeler

Economic Burden Comorbidities Obesity

Kaynakça

  • 1. Yates, N., Teuner, C. M., Hunger, M., Holle, R., Stark, R., Laxy, M., Wolfenstetter, S. B. (2016). The Economic Burden of Obesity in Germany: Results from the Population-Based KORA Studies. Obesity Facts, 397–409.
  • 2. Raebel, M. A., Malone, D. C., Conner, D. A., Xu, S., Porter, J. A., Lanty, F. A. (2004). Health services use and health care costs of obese and nonobese individuals. Archives of Internal Medicine, 164, 2135–2140.
  • 3. Lehnert, T., Sonntag, D., Konnopka, A., Riedel-Heller, S., König, H.-H. (2013). Economic costs of overweight and obesity. Best Practice & Research Clinical Endocrinology & Metabolism, 27(2), 105–115.
  • 4. Zhao, W., Zhai, Y., Hu, J., Wang, J., Yang, Z., Kong, L., Chen, C. (2008). Economic burden of obesity-related chronic diseases in Mainland China. Obesity Reviews, 9(SUPPL. 1), 62–67.
  • 5. Park, J.-H., Yoon, S.-J., Lee, H., Jo, H.-S., Lee, S.-I., Kim, Y., … Shin, Y. (2006). Burden of disease attributable to obesity and overweight in Korea. International Journal of Obesity (2005), 30(11), 1661–1669
  • 6. Müller-Riemenschneider, F., Reinhold, T., Berghöfer, A., Willich, S. N. (2008). Health-economic burden of obesity in Europe. European Journal of Epidemiology, 23(8), 499–50
  • 7. OECD. Health at a Glance 2017: OECD Indicators, OECD Publishing, Paris.
  • 8. Kim, D. D., & Basu, A. (2016). Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value in Health, 19(5), 602–613.
  • 9. Erem, C. (2015). Prevalence of Overweight and Obesity in Turkey. IJC Metabolic & Endocrine, 8, 38–41.
  • 10. Kockaya, G., Ergin, G., Atikeler, K., Tatar, M., Ozmen, M., Gorgun, M.,Taskin, M. (2013). Operational Cost of Obesity Surgery for Turkey. Obesity Surgery, 23(8), 1142–1143.
  • 11. WHO. (2009). Global health risks: mortality and burden of disease attributable to selected major risks. WHO Press. Switzerland: WHO Press,.
  • 12. Wang, L. Y., Denniston, M., Lee, S., Galuska, D., Lowry, R. (2010). Long-term Health and Economic Impact of Preventing and Reducing Overweight and Obesity in Adolescence. Journal of Adolescent Health, 46(5), 467–473.
  • 13. Buchmueller, T. C., Johar, M. (2015). Obesity and health expenditures: Evidence from Australia. Economics and Human Biology, 17, 42–58
  • 14. Birmingham, C. L., Muller, J. L., Palepu, A., Spinelli, J. J., Anis, A. H. (1999). The cost of obesity in Canada. Canadian Medical Association Journal, 160(4), 483–488.
  • 15. Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Vos, T. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology, 16(11), 877–897.
  • 16. Specchia, M. L., Veneziano, M. A., Cadeddu, C., Ferriero, A. M., Mancuso, A., Ianuale, C., Ricciardi, W. (2015). Economic impact of adult obesity on health systems: A systematic review. European Journal of Public Health, 25(2), 255–262
  • 17. Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy [Internet]. Seattle, WA: IHME. 2013.
  • 18. ox-Rushby, J. A. (2002). Disability Adjusted Life Years (DALYs) for Decision-making? An Overview of the Literature. Office of Health Economic.173 p.
  • 19. Devleesschauwer B, Havelaar AH, Maertens De Noordhout C, Haagsma JA, Praet N, Dorny P, et al. (2014) Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health, 59(3):565–9.
  • 20. Struijk, E. A., May, A. M., Beulens, J. W. J., de Wit, G. A., Boer, J. M. A., Onland-Moret, N. C., Peeters, P. H. M. (2013). Development of Methodology for Disability-Adjusted Life Years (DALYs) Calculation Based on Real-Life Data. PLoS ONE, 8(9)
  • 21. Sassi, F. (2006). Calculating QALYs, comparing QALY and DALY calculations. Health Policy and Planning, 21(5), 402–408
  • 22. Rios-Diaz, A. J., Lam, J., Ramos, M. S., Moscoso, A. V., Vaughn, P., Zogg, C. K., & Caterson, E. J. (2016). Global patterns of QALY and DALY use in surgical cost-utility analyses: A systematic review. PLoS ONE, 11(2), 1–13
  • 23. Whitehead, S. J., Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96(1), 5–21
  • 24. Robberstad, B. (2005). QALY vs DALY vs LYs gained: What are the difference, and what difference do they make for health care priority setting? Norsk Epidemiologi, 15(2), 183–191
  • 25. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Gakidou, E. (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 384(9945), 766–781.
  • 26. WHO, Disability-adjusted life year,, http://www.who.int/gho/, date of access: 11.12.2017
  • 27. Wiki Commons, https://commons.wikimedia.org/ wiki/File:DALY_.png, date of access: 10.10.2017
  • 28. Ministry of Health (2013). Moving Life And Healthy Nutrition Program in Turkey, Turkish Public Health Institution, Ankara.
  • 29. Ministry of Health, Role of Obesity Treatment of Obesity Surgery in Turkey (2014), Republic of Turkey Ministry of Health Directorate General for Research, Ankara.
  • 30. Dobbs, R., Sawers, C., Thompson, F., Manyika, J., Woetzel, J., Child, P., Spatharou, A. (2014). Overcoming obesity: An initial economic analysis. 2014. McKinsey & Company: www. mckinsey. com/mgi, 1-106.
  • 31. OECD (2017), “Obesity Update”, OECD Publishing, Paris, http:// www.oecd.org/els/health-systems/Obesity-Update-2017.pdf
  • 32. Ünüvar, N., Mollahaliloglu, S., Yardim, N. (2004). Turkey Burden of Disease Study. Ankara: Ministry of Health.

Economic Burden of Obesity-Related Comorbidities in Turkey

Yıl 2019, Cilt: 8 Sayı: 3, 223 - 230, 30.09.2019

Arzu Yiğit , Vahit Yiğit

Öz

Obesity and obesity-related diseases are the leading cause of death worldwide, and mortality and morbidities they cause are important public health problems. The purpose of this study, obesity-related comorbidities is to analyze the economic burden for 2004 and 2015 in Turkey. The most important of the methods used to study the burden of disease is the Disability-Adjusted Life Years (DALYs) approach. DALY and gross domestic product (GDP) per capita were used to estimate the economic burden of obesity. Obesity and related DALYs values were taken from the "Turkey Burden of Disease Study" published by the Ministry of Health. The economic burden of obesity-causing diseases has been estimated according to DALY methodology. Economic burden of obesityrelated comorbidities to Turkey in 2004 was estimated to be 4.692.333.776-$. This amounts to 1.20% of gross domestic product. In 2015, the economic burden of obesity-related  comorbidities is 17.646.245.880- $ and 2.45% of gross domestic product. Given the increase in obese population, the economic burden of obesity-related diseases is expected to increase further in the coming years. Obesity-related comorbidities represent a substantial financial burden to the Turkey budget. Obesity is an important public health problem that can be treated. In order to use scarce resources devoted to health services more efficiently and effectively, it is indispensable to considerably reduce the economic burden of obesity in Turkey.  

Kaynakça

  • 1. Yates, N., Teuner, C. M., Hunger, M., Holle, R., Stark, R., Laxy, M., Wolfenstetter, S. B. (2016). The Economic Burden of Obesity in Germany: Results from the Population-Based KORA Studies. Obesity Facts, 397–409.
  • 2. Raebel, M. A., Malone, D. C., Conner, D. A., Xu, S., Porter, J. A., Lanty, F. A. (2004). Health services use and health care costs of obese and nonobese individuals. Archives of Internal Medicine, 164, 2135–2140.
  • 3. Lehnert, T., Sonntag, D., Konnopka, A., Riedel-Heller, S., König, H.-H. (2013). Economic costs of overweight and obesity. Best Practice & Research Clinical Endocrinology & Metabolism, 27(2), 105–115.
  • 4. Zhao, W., Zhai, Y., Hu, J., Wang, J., Yang, Z., Kong, L., Chen, C. (2008). Economic burden of obesity-related chronic diseases in Mainland China. Obesity Reviews, 9(SUPPL. 1), 62–67.
  • 5. Park, J.-H., Yoon, S.-J., Lee, H., Jo, H.-S., Lee, S.-I., Kim, Y., … Shin, Y. (2006). Burden of disease attributable to obesity and overweight in Korea. International Journal of Obesity (2005), 30(11), 1661–1669
  • 6. Müller-Riemenschneider, F., Reinhold, T., Berghöfer, A., Willich, S. N. (2008). Health-economic burden of obesity in Europe. European Journal of Epidemiology, 23(8), 499–50
  • 7. OECD. Health at a Glance 2017: OECD Indicators, OECD Publishing, Paris.
  • 8. Kim, D. D., & Basu, A. (2016). Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value in Health, 19(5), 602–613.
  • 9. Erem, C. (2015). Prevalence of Overweight and Obesity in Turkey. IJC Metabolic & Endocrine, 8, 38–41.
  • 10. Kockaya, G., Ergin, G., Atikeler, K., Tatar, M., Ozmen, M., Gorgun, M.,Taskin, M. (2013). Operational Cost of Obesity Surgery for Turkey. Obesity Surgery, 23(8), 1142–1143.
  • 11. WHO. (2009). Global health risks: mortality and burden of disease attributable to selected major risks. WHO Press. Switzerland: WHO Press,.
  • 12. Wang, L. Y., Denniston, M., Lee, S., Galuska, D., Lowry, R. (2010). Long-term Health and Economic Impact of Preventing and Reducing Overweight and Obesity in Adolescence. Journal of Adolescent Health, 46(5), 467–473.
  • 13. Buchmueller, T. C., Johar, M. (2015). Obesity and health expenditures: Evidence from Australia. Economics and Human Biology, 17, 42–58
  • 14. Birmingham, C. L., Muller, J. L., Palepu, A., Spinelli, J. J., Anis, A. H. (1999). The cost of obesity in Canada. Canadian Medical Association Journal, 160(4), 483–488.
  • 15. Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Vos, T. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology, 16(11), 877–897.
  • 16. Specchia, M. L., Veneziano, M. A., Cadeddu, C., Ferriero, A. M., Mancuso, A., Ianuale, C., Ricciardi, W. (2015). Economic impact of adult obesity on health systems: A systematic review. European Journal of Public Health, 25(2), 255–262
  • 17. Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy [Internet]. Seattle, WA: IHME. 2013.
  • 18. ox-Rushby, J. A. (2002). Disability Adjusted Life Years (DALYs) for Decision-making? An Overview of the Literature. Office of Health Economic.173 p.
  • 19. Devleesschauwer B, Havelaar AH, Maertens De Noordhout C, Haagsma JA, Praet N, Dorny P, et al. (2014) Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health, 59(3):565–9.
  • 20. Struijk, E. A., May, A. M., Beulens, J. W. J., de Wit, G. A., Boer, J. M. A., Onland-Moret, N. C., Peeters, P. H. M. (2013). Development of Methodology for Disability-Adjusted Life Years (DALYs) Calculation Based on Real-Life Data. PLoS ONE, 8(9)
  • 21. Sassi, F. (2006). Calculating QALYs, comparing QALY and DALY calculations. Health Policy and Planning, 21(5), 402–408
  • 22. Rios-Diaz, A. J., Lam, J., Ramos, M. S., Moscoso, A. V., Vaughn, P., Zogg, C. K., & Caterson, E. J. (2016). Global patterns of QALY and DALY use in surgical cost-utility analyses: A systematic review. PLoS ONE, 11(2), 1–13
  • 23. Whitehead, S. J., Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96(1), 5–21
  • 24. Robberstad, B. (2005). QALY vs DALY vs LYs gained: What are the difference, and what difference do they make for health care priority setting? Norsk Epidemiologi, 15(2), 183–191
  • 25. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Gakidou, E. (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 384(9945), 766–781.
  • 26. WHO, Disability-adjusted life year,, http://www.who.int/gho/, date of access: 11.12.2017
  • 27. Wiki Commons, https://commons.wikimedia.org/ wiki/File:DALY_.png, date of access: 10.10.2017
  • 28. Ministry of Health (2013). Moving Life And Healthy Nutrition Program in Turkey, Turkish Public Health Institution, Ankara.
  • 29. Ministry of Health, Role of Obesity Treatment of Obesity Surgery in Turkey (2014), Republic of Turkey Ministry of Health Directorate General for Research, Ankara.
  • 30. Dobbs, R., Sawers, C., Thompson, F., Manyika, J., Woetzel, J., Child, P., Spatharou, A. (2014). Overcoming obesity: An initial economic analysis. 2014. McKinsey & Company: www. mckinsey. com/mgi, 1-106.
  • 31. OECD (2017), “Obesity Update”, OECD Publishing, Paris, http:// www.oecd.org/els/health-systems/Obesity-Update-2017.pdf
  • 32. Ünüvar, N., Mollahaliloglu, S., Yardim, N. (2004). Turkey Burden of Disease Study. Ankara: Ministry of Health.
Toplam 32 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Makaleleri
Yazarlar

Arzu Yiğit 0000-0002-5777-3405

Vahit Yiğit 0000-0002-9805-8504

Yayımlanma Tarihi 30 Eylül 2019
Yayımlandığı Sayı Yıl 2019 Cilt: 8 Sayı: 3

Kaynak Göster

APA Yiğit, A., & Yiğit, V. (2019). Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 8(3), 223-230.
AMA Yiğit A, Yiğit V. Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Sağlık Bilimleri Dergisi. Eylül 2019;8(3):223-230.
Chicago Yiğit, Arzu, ve Vahit Yiğit. “Economic Burden of Obesity-Related Comorbidities in Turkey”. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 8, sy. 3 (Eylül 2019): 223-30.
EndNote Yiğit A, Yiğit V (01 Eylül 2019) Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 8 3 223–230.
IEEE A. Yiğit ve V. Yiğit, “Economic Burden of Obesity-Related Comorbidities in Turkey”, Gümüşhane Sağlık Bilimleri Dergisi, c. 8, sy. 3, ss. 223–230, 2019.
ISNAD Yiğit, Arzu - Yiğit, Vahit. “Economic Burden of Obesity-Related Comorbidities in Turkey”. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 8/3 (Eylül 2019), 223-230.
JAMA Yiğit A, Yiğit V. Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Sağlık Bilimleri Dergisi. 2019;8:223–230.
MLA Yiğit, Arzu ve Vahit Yiğit. “Economic Burden of Obesity-Related Comorbidities in Turkey”. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, c. 8, sy. 3, 2019, ss. 223-30.
Vancouver Yiğit A, Yiğit V. Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Sağlık Bilimleri Dergisi. 2019;8(3):223-30.
 Kapak Resmi İndir